BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.06% | -12.37% | -35.86% | 19.88% | -62.59% |
| Total Depreciation and Amortization | -88.32% | 11.53% | 5.20% | 1.94% | 1,037.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -133.87% | -153.04% | -9.49% | -161.69% | -35.12% |
| Change in Net Operating Assets | 1,370.44% | -235.66% | 37.81% | 33.74% | 83.93% |
| Cash from Operations | 20.56% | -28.31% | -32.96% | -17.34% | 4.86% |
| Capital Expenditure | 59.92% | 44.95% | 92.45% | 100.38% | 67.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -728.57% | -1,700.00% | -678.26% | 88.24% |
| Cash from Investing | 59.95% | 42.37% | 92.25% | 98.21% | 67.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.66% | 25.71% | 21.08% | 21.30% | -29.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -10.85% | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -234.77% | -- |
| Cash from Financing | -113.03% | -10.76% | 23.05% | 67.19% | 970.62% |
| Foreign Exchange rate Adjustments | 60.04% | -150.49% | -221.77% | 215.27% | 11.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.35% | -18.87% | -47.74% | 17.60% | 33.64% |